Connect Biopharma Holdings (CNTB) Balance Sheet: Assets & Liabilities

Connect Biopharma Holdings (CNTB) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), Connect Biopharma Holdings reported total assets of $56.08M and total liabilities of $14.10M. Shareholders' equity was $41.98M, down 54.5% from $92.17M a year earlier. Total debt stood at $690.00K against $44.34M in cash and short-term investments, a net cash position of $43.65M. That puts debt-to-equity at 0.02, compared with 0.00 a year earlier.

Connect Biopharma Holdings Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Connect Biopharma Holdings Limited (CNTB) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2021	FY 2020	FY 2019
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Mar 2022	Jan 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	38.35	38.35	78.23	78.23	105.66	79.01	267.72	267.72	267.72	154.72	6.41
Short-Term Investments	6.00	6.00	15.48	15.48	12.64	73.41	0.00	-	-	0.59	0.64
Cash & Short-Term Investments	44.34	44.34	93.71	93.71	118.30	152.42	267.72	267.72	267.72	157.31	7.04
Accounts Receivable	0.16	0.16	1.05	1.05	0.35	0.23	7.41	7.41	7.41	0.04	0.03
Inventory	0.00	-	0.00	-	0.00	0.00	0.00	-	-	0.00	0.00
Other Current Assets	6.43	6.43	2.20	2.20	0.05	3.31	0.00	-	-	4.56	0.46
Total Current Assets	50.93	50.93	96.96	96.96	122.55	155.78	275.13	275.13	275.13	161.87	7.52
Non-Current Assets
Property, Plant & Equipment (Net)	4.46	4.46	4.24	4.24	4.74	5.38	9.44	12.89	9.44	1.21	0.07
Long-Term Investments	0.00	-	0.00	-	0.00	9.44	0.00	-	-	0.00	0.00
Intangible Assets	0.05	0.05	0.05	0.05	0.06	3.17	3.54	0.09	3.54	0.05	0.00
Other Non-Current Assets	0.65	0.65	0.03	0.03	0.02	0.03	2.95	2.95	2.95	3.04	0.13
Total Non-Current Assets	5.15	5.15	4.32	4.32	4.82	18.23	15.93	-	15.93	0.66	0.20
Total Assets	56.08	56.08	101.28	101.28	127.38	174.01	291.05	291.05	291.05	166.17	7.73
Current Liabilities
Accounts Payable	1.96	1.96	0.34	0.34	2.21	11.94	12.74	12.74	12.74	3.77	0.47
Short-Term Debt	0.32	-	0.15	-	0.29	0.19	0.10	-	-	0.01	0.01
Accrued Liabilities	-	11.16	-	7.80	7.43	0.82	-	-	2.32	1.87	-
Deferred Revenue	0.17	0.17	0.16	0.16	13.32	0.00	0.00	-	-	0.00	0.00
Other Current Liabilities	11.16	-	7.80	-	9.48	0.54	5.15	5.15	-	0.08	0.09
Total Current Liabilities	13.61	13.61	8.46	8.46	25.29	15.62	17.99	17.99	17.99	5.82	0.57
Non-Current Liabilities
Long-Term Debt	0.37	0.37	0.02	0.02	0.18	0.25	0.03	-	0.03	317.30	0.01
Other Non-Current Liabilities	0.11	0.11	0.63	0.63	0.41	0.00	0.00	-	-	48.57	13.33
Total Non-Current Liabilities	0.48	0.48	0.66	0.66	0.59	0.90	0.81	-	0.81	48.58	13.34
Total Liabilities	14.10	14.10	9.12	9.12	25.88	16.52	18.80	18.80	18.80	323.16	13.91
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00
Retained Earnings	-400.84	-400.84	-345.36	-345.36	-329.73	-479.84	-361.75	-361.75	-361.75	-164.10	-6.06
Accumulated Other Comprehensive Income	-1.19	-1.19	-1.67	-1.67	-1.01	-7.63	5.54	5.54	-4.03	0.75	-7.07
Treasury Stock	-	0.18	-	0.18	0.18	0.18	-	-	0.18	-	-
Additional Paid-in Capital	444.00	444.18	439.18	439.36	432.40	628.66	628.78	-	628.64	7.36	6.09
Shares Outstanding	-	56.44	-	55.35	55.10	55.04	-	-	55.08	-	-
Total Stockholders' Equity	41.98	41.98	92.17	92.17	101.50	157.49	272.26	272.26	272.26	-156.99	-6.18
Total Liabilities & Equity	56.08	56.08	101.28	101.28	127.38	174.01	291.39	-	291.05	166.19	54.05

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Connect Biopharma Holdings Balance Sheet

How much debt does Connect Biopharma Holdings have?

Connect Biopharma Holdings had total debt of $690.00K as of Mar 31, 2026, against $44.34M in cash and short-term investments. Its debt-to-equity ratio was 0.02. Total debt was $178.00K a year earlier.

What are Connect Biopharma Holdings's total assets?

Connect Biopharma Holdings reported total assets of $56.08M as of Mar 31, 2026, down 44.6% from $101.28M a year earlier. Total liabilities were $14.10M.

What is Connect Biopharma Holdings's shareholders' equity?

Connect Biopharma Holdings's shareholders' equity was $41.98M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition